Invited Perspective on the "Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-label Extension of a Phase 3 Randomized Controlled Trial".

Hinkle, Jared T; Pontone, Gregory M

Hinkle, Jared T; Pontone, Gregory M.

Affiliation

Hinkle JT; Medical Scientist Training Program, Johns Hopkins University, School of Medicine, Baltimore, MD; Departments of Psychiatry and Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Pontone GM; Departments of Psychiatry and Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: gpontone@jhmi.edu.

Am J Geriatr Psychiatry ; 30(3): 329-331, 2022 03.

Article in En | MEDLINE | ID: mdl-34429237

Subject(s)

Lewy Body Disease; Parkinsonian Disorders; Double-Blind Method; Humans; Lewy Body Disease/complications; Lewy Body Disease/drug therapy; Parkinsonian Disorders/complications; Parkinsonian Disorders/drug therapy; Zonisamide/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinsonian Disorders / Lewy Body Disease Type of study: Clinical_trials Limits: Humans Language: En Journal: Am J Geriatr Psychiatry Journal subject: GERIATRIA / PSIQUIATRIA Year: 2022 Type: Article Affiliation country: Moldova

Fulltext

XML

PubMed Links

Search on Google